HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kiyoshi Misawa Selected Research

Type 2 Galanin Receptor

9/2014Galanin receptor 2 utilizes distinct signaling pathways to suppress cell proliferation and induce apoptosis in HNSCC.
1/2014Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer.
3/2010Galanin receptor subtypes 1 and 2 as therapeutic targets in head and neck squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kiyoshi Misawa Research Topics

Disease

36Squamous Cell Carcinoma of Head and Neck
01/2022 - 12/2008
29Neoplasms (Cancer)
01/2022 - 03/2002
17Head and Neck Neoplasms (Head and Neck Cancer)
08/2020 - 12/2008
10Carcinogenesis
04/2021 - 01/2012
5Carcinoma (Carcinomatosis)
03/2020 - 11/2002
4Oropharyngeal Neoplasms
09/2020 - 01/2015
4Neoplasm Metastasis (Metastasis)
12/2019 - 03/2002
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2019 - 03/2002
2Hearing Loss (Hearing Impairment)
01/2022 - 06/2018
2Sensorineural Hearing Loss
06/2018 - 01/2009
2Cicatrix (Scar)
09/2017 - 10/2015
2Vocal Cord Paralysis
09/2017 - 02/2014
2Infections
01/2009 - 01/2007
2Cytomegalovirus Infections (Inclusion Disease)
01/2009 - 01/2007
1Hypercholesterolemia
06/2021
1Hyperkalemia
06/2021
1Hyperphosphatemia
06/2021
1Virus Diseases (Viral Diseases)
04/2021
1Dysphonia (Spastic Dysphonia)
01/2021
1Edema (Dropsy)
01/2021
1Genomic Instability
01/2020
1Adenocarcinoma
12/2019
1Inborn Genetic Diseases (Disease, Hereditary)
01/2019
1Facial Paralysis (Facial Palsy)
06/2018
1Gaucher Disease (Gaucher's Disease)
06/2018
1renal Oncocytoma
04/2018
1Renal Cell Carcinoma (Grawitz Tumor)
04/2018
1Laryngeal Neoplasms (Laryngeal Cancer)
01/2018
1Hypopharyngeal Neoplasms
01/2018
1Mouth Neoplasms (Oral Cancer)
01/2018
1Small Cell Carcinoma
05/2016
1Breast Neoplasms (Breast Cancer)
01/2016
1Papillomavirus Infections
01/2016
1Paralysis (Palsy)
10/2015
1Mucoepidermoid Carcinoma
09/2015

Drug/Important Bio-Agent (IBA)

19Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2012
11GalaninIBA
06/2018 - 04/2009
10Galanin Receptors (Galanin Receptor)IBA
01/2019 - 04/2009
6DNA (Deoxyribonucleic Acid)IBA
04/2021 - 01/2007
6Proteins (Proteins, Gene)FDA Link
08/2020 - 08/2015
6Messenger RNA (mRNA)IBA
08/2020 - 03/2014
3Circulating Tumor DNAIBA
01/2022 - 01/2020
3Biological ProductsIBA
04/2021 - 06/2018
3G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
09/2020 - 08/2015
3alpha2 Subunit Collagen Type IIBA
01/2018 - 01/2012
3somatostatin receptor type 1IBA
01/2018 - 01/2015
3Type 1 Galanin ReceptorIBA
01/2017 - 12/2008
3Tachykinin Receptors (Tachykinin Receptor)IBA
08/2015 - 05/2013
3Cyclin D1IBA
08/2015 - 12/2008
3Type 2 Galanin ReceptorIBA
09/2014 - 03/2010
2Hormones (Hormone)IBA
01/2021 - 06/2018
25-hydroxymethylcytosineIBA
01/2021 - 01/2019
2ElementsIBA
01/2020 - 05/2016
2NucleotidesIBA
01/2020 - 01/2016
2Neuropeptide Receptors (Neuropeptide Receptor)IBA
01/2020 - 09/2017
2EnzymesIBA
01/2019 - 06/2018
2DNA Glycosylases (DNA Glycosylase)IBA
01/2019 - 01/2016
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
09/2017 - 10/2015
2Indicators and Reagents (Reagents)IBA
07/2017 - 11/2002
2Cadherins (E-Cadherin)IBA
05/2016 - 05/2013
2H-cadherin (T-cadherin)IBA
05/2016 - 01/2012
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2015 - 03/2002
2CollagenIBA
03/2014 - 01/2012
1ORALIT (ORS)IBA
01/2022
1Opioid Receptors (Opioid Receptor)IBA
01/2022
1InflammasomesIBA
01/2022
1Ion Exchange ResinsIBA
06/2021
1Therapeutic UsesIBA
01/2021
1Small Interfering RNA (siRNA)IBA
08/2020
1Transcription Factors (Transcription Factor)IBA
08/2020
1DNA Methyltransferase 3AIBA
08/2020
1ProstaglandinsIBA
01/2020
1Retroelements (Retrotransposon)IBA
01/2020
1Phosphates (Orthophosphate)IBA
12/2019
1LanthanumIBA
12/2019
1DioxygenasesIBA
01/2019
1human ERBB2 proteinIBA
06/2018
1Glucosylceramidase (Glucocerebrosidase)IBA
06/2018
1ChloridesIBA
04/2018
1NeuropeptidesIBA
01/2018
1DecitabineFDA Link
10/2017
1trichostatin A (A 300)IBA
10/2017
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
07/2017
1Aromatase InhibitorsIBA
01/2016
1Cisplatin (Platino)FDA LinkGeneric
09/2015
1Paclitaxel (Taxol)FDA LinkGeneric
09/2015
1Interleukin-6 (Interleukin 6)IBA
09/2015
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
09/2015
1tocilizumab (atlizumab)FDA Link
09/2015

Therapy/Procedure

6Therapeutics
01/2022 - 04/2009
3Neck Dissection (Radical Neck Dissection)
01/2020 - 05/2016
3Drug Therapy (Chemotherapy)
11/2018 - 09/2015
2Cochlear Implants (Cochlear Implant)
06/2018 - 01/2009
2Cochlear Implantation
06/2018 - 01/2009
2Injections
09/2017 - 10/2015
1Chemoradiotherapy
04/2020
1Palliative Care (Palliative Therapy)
03/2020
1Contraindications
03/2020
1Laryngectomy
05/2016
1Mastectomy (Mammectomy)
01/2016